Background Seasonal malaria chemoprevention is used in 13 countries in the Sahel region
of Africa to prevent malaria in children younger than 5 years. Resistance of Plasmodium …

Background In 2012, seasonal malaria chemoprevention (SMC) was recommended as
policy for malaria control by the World Health Organization (WHO) in areas of highly …

Malaria is a significant public health problem in Ghana. Seasonal Malaria Chemoprevention
(SMC) using a combination of sulfadoxine-pyrimethamine and amodiaquine has been …

Background Zanzibar has recently undergone a rapid decline in Plasmodium falciparum
transmission following combined malaria control interventions with artemisinin-based …

Abstract Background. In 2007, Malawi replaced sulfadoxine-pyrimethamine (SP) with an
artemisinin-based combination therapy as the first-line treatment for uncomplicated …

One of the fundamental steps toward malaria control is the use of antimalarial drugs. The
success of antimalarial treatment can be affected by the presence of drug-resistant …

Faced with intense levels of chloroquine (CQ) resistance in Plasmodium falciparum malaria,
Rwanda replaced CQ with amodiaquine (AQ)+ sulfadoxine-pyrimethamine (SP) in 2001 …

Background Despite evident success of malaria control in many sites in the Arabian
Peninsula, malaria remains endemic in a few spots, in Yemen and south-west of Saudi …

Background. Analysis of genome-wide polymorphism in many organisms has potential to
identify genes under recent selection. However, data on historical allele frequency changes …

Background Plasmodium falciparum is an apicomplexan parasite responsible for lethal
cases of malaria. According to WHO recommendations, P falciparum cases are treated with …